ESC 365 - Revisiting risk stratification in hypertrophic cardiomyopathy after the recent guidelines

Back

ESC Professional Premium Access

Revisiting risk stratification in hypertrophic cardiomyopathy after the recent guidelines - LGE remains tough to beat

Session: Prognostication in left ventricular hypertrophy: role of cardiac magnetic resonance imaging

Topic: Late Gadolinium Enhancement

Speaker: Doctor R. Amador (Lisbon, PT)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Rita Amador

Hospital Santa Cruz, Lisbon (Portugal)

1 presentation

0 follower

4 more presentations in this session

Incremental prognostic value of late gadolinium enhancement granularity in patients with hypertrophic cardiomyopathy

Speaker: Mr J. Florence (Paris, FR)

Left atrioventricular coupling index is an independent associate of new-onset AF and stroke in hypertrophic cardiomyopathy: a CMR study

Speaker: Doctor M. De Raffele (Ferrara, IT)

CMR-derived pulmonary artery to aorta ratio as a predictor of adverse outcome in patients with cardiac transthyretin amyloidosis

Speaker: Doctor C. Kronberger (Vienna, AT)

The prognostic and incremental value of T1 mapping for predicting adverse events in hypertrophic cardiomyopathy

Speaker: Doctor J. Wang (Chengdu, CN)

Access the full session

Prognostication in left ventricular hypertrophy: role of cardiac magnetic resonance imaging

Speakers: Doctor R. Amador, Mr J. Florence, Doctor M. De Raffele, Doctor C. Kronberger, Doctor J. Wang

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources